• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Dynavax Technologies Corp

+ Add to Watchlist


1.4200 USD 0.0700 5.19%

As of 15:52:24 ET on 09/19/2014.

Snapshot for Dynavax Technologies Corp (DVAX)

Open: 1.3500 Day's Range: 1.3400 - 1.4500 Volume: 1,841,815
Previous Close: 1.3500 52wk Range: 1.1000 - 2.1400 1-Yr Rtn: +20.76%

Stock Chart for DVAX

No chart data available.
  • DVAX:US 1.4200
  • 1D
  • 1M
  • 1Y
Interactive DVAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DVAX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3063
Est. EPS (USD) (12/2014) -0.3380
Est. PEG Ratio -
Market Cap (M USD) 357.52
Shares Outstanding (M) 262.88
30 Day Average Volume 1,140,179
Price/Book (mrq) 2.4863
Price/Sale (ttm) 26.9035
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DVAX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DVAX

Dynavax Technologies Corporation discovers, develops, and is seeking to commercialize products based on immunostimulatory sequences. The Company is developing products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using approaches that alter immune system responses in specific ways.

Eddie GrayChief Executive OfficerRobert Lee CoffmanSenior VP/Chief Scientific
David L JohnsonVP/Chief Acctg OfficerMichael S OstrachVP/Chief Bus Ofcr/Secy/Gen Cnsl
More Company Profile & Key Executives for DVAX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil